https://www.businesswire.com/news/home/20211018005225/en/NFlection-Therapeutics-Appoints-William-Hodder-as-CEO-and-Expands-Leadership-Team-to-Accelerate-Development-of-Targeted-Treatments-for-Rare-Diseases
NFlection Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel drug candidates for rare RASopathies, today announced th...
william hoddertherapeuticsappointsceoexpands